Rigel Pharmaceuticals (RIGL) EBT Margin (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly EBT Margin of 19.82% for Q1 2026, down 176.0% year-over-year from 26.08% in Q1 2025, and down 39.1% quarter-over-quarter from 32.54% in Q4 2025.
Rigel Pharmaceuticals (RIGL) EBT Margin (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' EBT Margin history runs 16 years deep, the most recent figure standing at 19.82% for Q1 2026.
- In Q1 2026, EBT Margin fell 176.0% year-over-year to 19.82%; the TTM figure through Mar 2026 stood at 40.69% (up 2192.0% YoY), while the FY2025 annual figure was 41.4%, up 3115.0% from the prior year.
- EBT Margin for Q1 2026 stood at 19.82%, down from 32.54% in the prior quarter.
- The five-year high for EBT Margin was 58.99% in Q2 2025, with the low at 164.0% in Q1 2022.
- The 5-year median for EBT Margin is 0.17% (2023), against an average of 11.7%.
- Peak annual rise in EBT Margin reached 11396 bps in 2022, while the deepest fall reached 21494 bps in 2022.
- Rigel Pharmaceuticals' EBT Margin stood at 2.73% in 2022, then plunged by 106 bps to 0.17% in 2023, then soared by 15607 bps to 26.43% in 2024, then increased by 23 bps to 32.54% in 2025, then tumbled by 39 bps to 19.82% in 2026.
- Business Quant data shows RIGL's EBT Margin at 19.82% in Q1 2026, 32.54% in Q4 2025, and 39.76% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 29.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.97% |
| Mar 31, 2026 | 19.82% |
| Dec 31, 2025 | 32.54% |
| Sep 30, 2025 | 39.76% |
| Jun 30, 2025 | 58.99% |
| Mar 31, 2025 | 21.58% |
| Dec 31, 2024 | 26.43% |
| Sep 30, 2024 | 22.46% |
| Jun 30, 2024 | -2.80% |
| Mar 31, 2024 | -27.92% |
| Dec 31, 2023 | -0.17% |
| Sep 30, 2023 | -20.23% |
| Jun 30, 2023 | -24.55% |
| Mar 31, 2023 | -53.36% |
| Dec 31, 2022 | 2.73% |
| Sep 30, 2022 | -84.95% |
| Jun 30, 2022 | -45.25% |
| Mar 31, 2022 | -164.00% |
| Dec 31, 2021 | -111.23% |
| Sep 30, 2021 | -97.89% |